ephedrine has been researched along with sumatriptan in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Petro, DJ | 1 |
| Bellamy, JL; Cady, RK; Durham, PL | 1 |
1 review(s) available for ephedrine and sumatriptan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for ephedrine and sumatriptan
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Cerebral vasoconstriction and stroke after use of serotonergic drugs.
Topics: Antidepressive Agents; Brain; Cerebrovascular Circulation; Dietary Supplements; Drug and Narcotic Control; Ephedrine; Humans; Hypertension; Myocardial Infarction; Oxazolidinones; Risk; Serotonin Agents; Stroke; Sumatriptan; Syndrome; Tryptamines; Vasoconstriction | 2002 |
Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
Topics: Adolescent; Adult; Calcitonin Gene-Related Peptide; Ephedrine; Female; Humans; Male; Middle Aged; Migraine Disorders; Neuropeptides; Parasympathetic Nervous System; Rhinitis; Saliva; Salivary Proteins and Peptides; Sinusitis; Sumatriptan; Trigeminal Nerve; Vasoactive Intestinal Peptide; Vasoconstrictor Agents | 2006 |